期刊文献+

熊去氧胆酸选择性诱导人肝肿瘤细胞凋亡及抑制增殖的实验研究 被引量:5

An experimental study on UDCA-selectively induced apoptosis and inhibited proliferation to human hepatoma cell lines
下载PDF
导出
摘要 目的探讨熊去氧胆酸(UDCA)对肝肿瘤细胞株诱导凋亡及抑制增殖的作用和机制。方法用四氮唑蓝法、流式细胞术、脱氧核糖核苷酸末端转移酶介导的缺口末端标记法、Wright-Giemsa染色法、电镜及免疫细胞化学等方法,观察UDCA对肝肿瘤细胞株HepG2、BEL7402和正常人肝细胞株L-02的生长活力、细胞凋亡、细胞周期及Bax/bcl-2基因表达的影响。结果UDCA对HepG2、BEL7402细胞株具有显著地抑制生长、诱导凋亡、阻滞细胞周期于S期、降低bcl-2和提升Bax表达的作用。UDCA对HepG2及BEL7402的IC50分别为0.92,0.86mmol/L。UDCA(1.0mmol/L)对HepG2及BEL7402的凋亡率分别为42%及44%,明显高于对照组(P<0.01)。UDCA对L-02细胞无明显作用。结论UDCA对HepG2、BEL7402细胞株有显著地抑制增殖及诱导凋亡作用,该作用可能与UDCA阻滞细胞周期、降低bcl-2和提升Bax的表达有关。 Purpose To investigate the effect of inducing apoptosis and inhibiting proliferation on hepatoma cell lines by UDCA, and mechanisms of the action. Methods UDCA effect of cell proliferation, apoptosis, cell cycle and the expression of Bax/bcl-2 genes on two human hepatoma cell lines HepG2 and BEL7402, and normal human hepatic cell line L-02 in vitro was detected by MTT assay, flow eytometry, TUNEL assay, Wright-Giemsa staining, electron microscopy and immunoeytoehemistry. Results UDCA could strongly inhibit the proliferation, induce apoptosis, arrest cell cycle to S phase, down-regulate bel-2 and up-regulate Bax gene expression of HepG2 and BEL7402 cell lines. The IC50 to HepG2 and BEL7402 were 0.92,0.86 mmol/L, respectively. The apoptosis rates (UDCA/1.0mmol/L) of HepG2 and BEL7402 were 42% and 44%, respectively, the rates were significantly higher than those of L-02 (P 〈 0.01). UDCA had no obvious effect on L-02 cell line. Conclusion UDCA maybe selectively inhibits proliferation and induces apoptosis of HepG2 and BEL7402 cell lines by blocking cell cycle and regulating the expression of Bax/bel-2 genes.
出处 《中国生化药物杂志》 CAS CSCD 2005年第4期199-202,共4页 Chinese Journal of Biochemical Pharmaceutics
关键词 熊去氧胆酸 肝肿瘤 细胞凋亡 细胞株 ursodeoxycholic acid liver neoplasms apoptosis cell lines
  • 相关文献

参考文献6

  • 1Wali RK, Stoiber D, Nguyen L, et al. Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development [ J ], Cancer Epidemiol Biomarkers Prey, 2002, 11 :1316-1321.
  • 2le EO, Choi YH, Paik KJ, et al. Novel bile acid derivatives induce apoptosis via a p53-independent pathway in human breast carcinomacells[J]. Cancer Lett,2001,163:83-93.
  • 3Oyarfm K ,Shiota G ,Ito H, et al. Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats[J]. Carclnogenesis,2002,23:885-892.
  • 4谢青,李光明,周霞秋,廖丹,俞红,郭清.牛磺酸熊脱氧胆酸对细胞色素C介导HepG2细胞凋亡的作用[J].中华肝脏病杂志,2003,11(5):298-301. 被引量:7
  • 5Arafat WO, Gomez-Navarro J, Xiang J, et al. An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect inhuman ovarian cancer[J]. Mol Ther,2000,1 (6):545-554.
  • 6Hotchkiss RS, Swanson PE, Knudson CM, et al. Overexpression of bcl-2 in transgenic ndce decreases apoptosis and improves survival in sepsis[J]. J Immunol, 1999,162(7) :4148-4156.

二级参考文献9

  • 1Kumar D, Tandon RK. Use of ursodeoxycholic acid in liver diseases.J Gastroenterol Hepatol, 2001, 16: 3-14.
  • 2Xie Q, Khaou Stov VL, Chung CC, et al. Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. Hepatology, 2002, 36: 592-601.
  • 3Rodrigues CM, Fan G, Ma X, et al. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest, 1998, 101: 2790-2799.
  • 4Columbano A. Cell death: current difficulties in discriminating apoptosis from necrosis in the context of pathological processes invivo. J Cell Biochem. 1995, 58: 181-190.
  • 5Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.Hepatology, 2002, 36: 525-531.
  • 6Finkel E. The mitochondrion: is it central to apoptosis? Science,2001, 292: 624-626.
  • 7Toshiyuki N, Hong Z, Nobuhiro M, et al.Caspase-12 mediates endoplasmic-reticulum specific apoptosis and cytotoxicity by amyloid[beta]. Nature, 2000, 403: 98-103.
  • 8Hengartner MO. The biochemistry of apoptosis. Nature, 2000, 407:770-776.
  • 9李光明,谢青,周霞秋.熊去氧胆酸在慢性肝病中的应用及机制[J].肝脏,2002,7(1):59-61. 被引量:22

共引文献6

同被引文献57

引证文献5

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部